Insider · CIK 0001314760

Forbes William P

Reports to the SEC for 4 companies · CARY, NC

sec.gov

Transactions

Companies

Filings

CIK

0001314760

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-31	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−11.7K sh	—	—	116,944
2026-07-31	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+11.7K sh	—	—	244,499
2026-07-31	HRTXHERON THERAPEUTICS, INC. /DE/F Tax Payment	EVP, Chief Development Officer	FTax Payment	−3,326 sh	$0.50	−$1,663	241,173
2026-07-30	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+11.8K sh	—	—	236,153
2026-07-30	HRTXHERON THERAPEUTICS, INC. /DE/F Tax Payment	EVP, Chief Development Officer	FTax Payment	−3,348 sh	$0.50	−$1,674	232,805
2026-07-30	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−11.8K sh	—	—	164,776
2026-07-19	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−3,874 sh	—	—	23,246
2026-07-19	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+3,874 sh	—	—	225,485
2026-07-19	HRTXHERON THERAPEUTICS, INC. /DE/F Tax Payment	EVP, Chief Development Officer	FTax Payment	−1,101 sh	$0.47	−$517.47	224,384
2026-06-06	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−12.5K sh	—	—	12,500
2026-06-06	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+12.5K sh	—	—	221,611
2026-04-30	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−11.8K sh	—	—	176,545
2026-04-30	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−11.7K sh	—	—	128,638
2026-04-30	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+11.8K sh	—	—	209,111
2026-04-30	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+11.7K sh	—	—	197,341
2026-04-19	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+3,874 sh	—	—	185,647
2026-04-19	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−3,874 sh	—	—	27,120
2026-01-31	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+11.7K sh	—	—	181,773
2026-01-31	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−11.7K sh	—	—	140,332
2026-01-30	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsA Award	EVP, Chief Development Officer	AAward	+188K sh	—	—	188,315
2026-01-30	HRTXHERON THERAPEUTICS, INC. /DE/ · Performance Stock UnitsA Award	EVP, Chief Development Officer	AAward	+188K sh	—	—	188,314
2026-01-19	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−3,875 sh	—	—	30,994
2026-01-19	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+3,875 sh	—	—	170,078
2025-11-04	XAIRBeyond Air, Inc. · Stock Options (Right to buy)A Award	Director	AAward	+400 sh	—	—	400
2025-11-04	XAIRBeyond Air, Inc. · Stock Options (Right to buy)A Award	Director	AAward	+2,000 sh	—	—	2,000
2025-11-04	XAIRBeyond Air, Inc. · Stock Options (Right to buy)A Award	Director	AAward	+2,250 sh	—	—	2,250
2025-11-04	XAIRBeyond Air, Inc. · Stock Options (Right to buy)A Award	Director	AAward	+1,250 sh	—	—	1,250
2025-11-04	XAIRBeyond Air, Inc. · Stock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,750 sh	—	—	0
2025-11-04	XAIRBeyond Air, Inc. · Stock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,500 sh	—	—	0
2025-11-04	XAIRBeyond Air, Inc. · Stock Options (Right to buy)A Award	Director	AAward	+3,750 sh	—	—	3,750
2025-11-04	XAIRBeyond Air, Inc. · Stock Options (Right to buy)A Award	Director	AAward	+1,250 sh	—	—	1,250
2025-11-04	XAIRBeyond Air, Inc. · Stock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,250 sh	—	—	0
2025-11-04	XAIRBeyond Air, Inc. · Stock Options (Right to buy)A Award	Director	AAward	+1,250 sh	—	—	1,250
2025-11-04	XAIRBeyond Air, Inc. · Stock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,250 sh	—	—	0
2025-11-04	XAIRBeyond Air, Inc. · Stock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,250 sh	—	—	0
2025-11-04	XAIRBeyond Air, Inc. · Stock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,000 sh	—	—	0
2025-11-04	XAIRBeyond Air, Inc. · Stock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,250 sh	—	—	0
2025-11-04	XAIRBeyond Air, Inc. · Stock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−400 sh	—	—	0
2025-11-04	XAIRBeyond Air, Inc. · Stock Options (Right to buy)A Award	Director	AAward	+1,500 sh	—	—	1,500
2025-10-31	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−11.7K sh	—	—	152,027
2025-10-31	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+11.7K sh	—	—	166,203
2025-10-19	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+3,874 sh	—	—	154,509
2025-10-19	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−3,874 sh	—	—	34,869
2025-07-31	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−11.7K sh	—	—	163,721
2025-07-31	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+11.7K sh	—	—	150,635
2025-07-19	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−3,874 sh	—	—	38,743
2025-07-19	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+3,874 sh	—	—	138,940
2025-06-06	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+12.5K sh	—	—	135,066
2025-06-06	HRTXHERON THERAPEUTICS, INC. /DE/ · Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	−12.5K sh	—	—	25,000
2025-04-30	HRTXHERON THERAPEUTICS, INC. /DE/M Exercise/Conversion	EVP, Chief Development Officer	MExercise/Conversion	+11.7K sh	—	—	122,566

Recent filings

Accepted (ET)
Aug 34
Forbes William P0001193125-26-329804
SEC(opens sec.gov)
Jul 204
Forbes William P0001193125-26-308922
SEC(opens sec.gov)
Jun 84
Forbes William P0001193125-26-260931
SEC(opens sec.gov)
May 44
Forbes William P0001193125-26-203344
SEC(opens sec.gov)
Apr 214
Forbes William P0001193125-26-165591
SEC(opens sec.gov)
Feb 34
Forbes William P0001193125-26-034627
SEC(opens sec.gov)
Feb 34
Forbes William P0001193125-26-034491
SEC(opens sec.gov)

Companies

Address

25 FENTON MAIN STREET SUITE 300

CARY, NC, 27511